• The use of this product carries the same risks associated with coronary artery stent implantation procedures, which include subacute and late vessel thrombosis, vascular complications and/or bleeding events. (medtronic.com)
  • Stent thrombosis is a low-frequency event that is frequently associated with MI or death. (medtronic.com)
  • Stent thrombosis is a low-frequency event that current drug-eluting stent (DES) clinical trials are not adequately powered to fully characterize. (bostonscientific.com)
  • Stent thrombosis is frequently associated with myocardial infarction (MI) or death. (bostonscientific.com)
  • In the clinical trials analyzed to date, differences in the incidence of stent thrombosis have not been associated with an increased risk of cardiac death, MI, or all-cause mortality. (bostonscientific.com)
  • Additional data from longer-term follow-up of the PLATINUM clinical trials and analyses of stent thrombosis related to DES are expected and should be considered in making treatment decisions as data become available. (bostonscientific.com)
  • They are mainly built to overcome the risk of late complications, such as scaffold thrombosis or restenosis, which can occur when the rigid metal backbone of a conventional metal stent remains permanently embedded in the diseased vessel. (inbit.gr)
  • Delayed arterial healing, characterized by poor endothelialization, is the primary cause of late (1 month-1 year postimplantation) and very late stent thrombosis following implantation of drug-eluting stents. (nature.com)
  • The incompetent endothelium leads to late stent thrombosis and the development of in-stent neoatherosclerosis. (nature.com)
  • However, There were still 8.0 % (5/62) of the patients with poor outcomes, including optic disc atrophy in 3 patients and stent-interior thrombosis in 2 patients, which occurred 6.3 months after stenting. (benthamscience.com)
  • Efficacy of stenting in patients with cerebral venous sinus thrombosis-related cerebral venous sinus stenosis. (benthamscience.com)
  • In addition, the efficacy of the stent configurations for promoting aneurysm thrombosis was assessed by simulations of residence time and platelet activation. (springer.com)
  • Mortality, major adverse cardiovascular events (MACEs), target vessel failure, and stent thrombosis (ST) occur more frequently as the result of calcium-mediated poor lesion preparation, stent under expansion, and stent malapposition ( 2 ). (frontiersin.org)
  • Various anticoagulation and antiplatelet regimens are used during and after PCI to reduce the incidence of thrombosis at the site of balloon dilation and stent placement. (msdmanuals.com)
  • Drug-eluting stents (DES) were developed in the early 2000s to reduce restenosis (ie, recurrent narrowing) rates in stented coronary lesions. (medscape.com)
  • [ 2 , 3 ] There was significant improvement in angiographic results (in stent late lumen loss: 0.17 mm vs 1.00 mm) as well as clinical outcomes (binary in-lesion restenosis: 8.9% vs 36.3%) in the sirolimus stent treatment group relative to the BMS group. (medscape.com)
  • [ 4 ] Restenosis remains an issue in coronary drug-eluting stent implantation for ostial RCA lesions. (medscape.com)
  • Subsequent stent restenosis or occlusion may require repeat catheter-based treatments (including balloon dilatation) of the arterial segment containing the stent. (medtronic.com)
  • The symptoms and signs of IH prior to stenting and post-stenting and the incidence of restenosis after stenting were analyzed. (benthamscience.com)
  • In 23 lesions, IVL was used for the treatment of in-stent restenosis (ISR). (frontiersin.org)
  • Drug-eluting stents (DES) are a standard metallic coronary stent with a polymer coating and an antiproliferative drug, which allows drug elution into the coronary wall for weeks to months after stent implantation. (medscape.com)
  • Drug-eluting stents (DES) are balloon-mounted, expandable, slotted tubular or multilink scaffolds constructed of a stainless steel or cobalt chromium matrix. (medscape.com)
  • However, off-label use of drug-eluting stents is extremely common. (medscape.com)
  • Initially, drug-eluting stents (DES) were compared to bare-metal stents (BMS) for efficacy. (medscape.com)
  • When drug-eluting stents (DES) are used outside the specified Indications for Use , patient outcomes may differ from the results observed in the RESOLUTE pivotal clinical trials. (medtronic.com)
  • The recent introduction of drug-eluting stents (DESs), together with advances in periprocedural and postprocedural adjunctive pharmacotherapies, has improved outcomes of PCIs of these lesions. (amrita.edu)
  • Recent studies comparing efficacy and safety of PCIs using drug-eluting stents and CABG revealed comparable results in terms of safety and a lower need for repeat revascularisation for CABG. (amrita.edu)
  • Impairment of vasorelaxation in nonstented proximal and distal segments of stented coronary arteries is more severe with drug-eluting stents than bare-metal stents, and stent-induced flow disturbances resulting in complex spatiotemporal shear stress can also contribute to increased thrombogenicity and inflammation. (nature.com)
  • The process of neoatherosclerosis occurs more rapidly, and more frequently, following deployment of drug-eluting stents than bare-metal stents. (nature.com)
  • Placement of a metal stent across a stenotic or occluded blood vessel is intended to maintain patency of and re-establish flow through the vessel by providing internal structural support. (medscape.com)
  • As the only commercially available bare metal stent FDA-approved for the superficial femoral and popliteal arteries, the LifeStent™ Vascular Stent has a history of proven performance. (bd.com)
  • These stents are FDA approved for single de novo coronary lesions of limited length within specific diameter size ranges. (medscape.com)
  • [ 1 ] which compared the sirolimus-eluting CYPHER stent with its noncoated counterpart, the BX velocity stent, in 238 patients with de novo lesions less than 18 mm in length in native coronary arteries 2.5-3.5 mm in diameter. (medscape.com)
  • The SIRIUS trial, which included 1058 patients with workhorse lesions who were randomly assigned to either sirolimus-eluting stents or BMS, demonstrated the long-term efficacy and safety of sirolimus-eluting stents. (medscape.com)
  • In a 5-year study of outcomes from the j-CYPHER registry which compared sirolimus-eluting stent treatment in 397 patients with ostial right coronary artery (RCA) lesions with 3716 patients with nonostial RCA lesions, researchers concluded that sirolimus-eluting stent implantation for ostial RCA was associated with a higher risk of target legion revascularization than when used in patients with nonostial RCA lesions. (medscape.com)
  • The Resolute Integrity Zotarolimus-Eluting Coronary Stent System is indicated for improving coronary luminal diameters in patients, including those with diabetes mellitus, with symptomatic ischemic heart disease due to de novo lesions of length ≤ 27 mm in native coronary arteries with reference vessel diameters of 2.25 mm to 4.20 mm. (medtronic.com)
  • Despite improvement in stent technology and operator experience, management can be challenging especially in LMCA bifurcation lesions and, therefore, an integrated approach combining advanced devices, tailored techniques, adjunctive support of physiological evaluation, and adjunctive pharmacological agents should be reinforced to improve clinical outcome. (amrita.edu)
  • The Promus ELITE Everolimus-Eluting Platinum Chromium Coronary Stent System is indicated for improving luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease or documented silent ischemia due to de novo lesions in native coronary arteries ≥2.25 mm to ≤4.00 mm in diameter in lesions ≤34 mm in length. (bostonscientific.com)
  • Significantly higher patency in complex TASC C&D lesions compared to bare metal stents at 5 years (p=0.003). (getinge.com)
  • The Advanta V12/iCast studies treated patients with more severe disease (a greater number of TASC C & D lesions) and more severe symptoms (more Rutherford classification 4 & 5) compared to patients enrolled in clinical trials studying other covered balloon-expandable stents. (getinge.com)
  • The LifeStent™ Vascular Stent is a peripheral stent intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 240mm in length in the native superficial femoral artery (SFA) and popliteal artery with reference vessel diameters ranging from 4.0 - 6.5mm. (bd.com)
  • Nitinol Stent Implantation vs. Balloon Angioplasty for Lesions in the Superficial Femoral and Proximal Popliteal Arteries of Patients With Claudication: Three-Year Follow-up From the RESILIENT Randomized Trial. (bd.com)
  • 3. RESILIENT I Trial, RESILIENT II Trial, E-TAGIUSS Trial, Retrospective Analysis of LifeStent® Vascular Stent Systems in the Treatment of Long-Segment Lesions, LifeStent® Vascular Stent Delivery System Study (LifeStent® 200 mm Trial),REALITY I Trial,REALITY II Trial, ETAP Trial, CONTINUUM Trial, and RELIABLE Trial. (bd.com)
  • A number of new balloon and stent technologies can be utilised with high long-term patency, but comparative data on these treatment strategies and in more complex lesions are lacking since both techniques showed high patency rates. (cirse.org)
  • Alternatively, primary stenting may be used for more complex aorto-iliac lesions. (cirse.org)
  • The objective was to demonstrate non-inferiority of the Express™ LD Stent for the treatment of atherosclerotic iliac artery lesions as compared to an objective performance criterion* (OPC), with a primary endpoint of mean percent luminal diameter loss at 6 months. (bostonscientific.com)
  • A total of 87 de novo lesions were treated by IVL with the following indications: 25 before attempting other balloon-based devices (primary IVL), 51 after the failure of non-compliant balloon dilatation (secondary IVL), and 11 after stent implantation because of stent under expansion (bailout IVL). (frontiersin.org)
  • Stents are used frequently for acute myocardial infarction, ostial or left main disease, chronic total occlusions, and bifurcation lesions. (msdmanuals.com)
  • Attached to the stent is a polymer that is embedded with an antiproliferative drug, which allows drug elution into the coronary wall for weeks to months after stent implantation to reduce the local proliferative healing response. (medscape.com)
  • Only physicians who have received adequate training should perform implantation of the stent. (medtronic.com)
  • The risks and benefits of the stent implantation should be assessed for patients with a history of severe reaction to contrast agents. (medtronic.com)
  • The Valiant thoracic stent graft with the Captivia delivery system is not recommended in patients who cannot undergo, or who will not be compliant with, the necessary preoperative and post-operative imaging and implantation procedures as described in the Instructions for Use . (medtronic.com)
  • MELODIE is a prospective, multi-center, single arm study to obtain additional data on the safety and efficacy of the Express™ Vascular LD stent implantation in the treatment of stenosed or occlusive atherosclerotic disease (de novo or restenotic) in iliac arteries (common or external). (bostonscientific.com)
  • Fully bioresorbable stents or scaffolds (BRS) represent the latest generation of devices for myocardial revascularisation strategies. (inbit.gr)
  • The final project plan of the assessment on "Bioresorbable Stents in cardiovascular indications (coronary artery disease)" and the comments provided by the external experts and the manufacturers are now available. (scuba-capsule.fr)
  • The Advanta V12 balloon expandable covered stent is indicated for restoring and improving the patency of the iliac and renal arteries. (getinge.com)
  • Compression resistance and conformability are crucial stent attributes that help improve vessel patency within tortuous vasculature. (bostonscientific.com)
  • A large stent diameter and synthetic covering over the tubular mesh prolong stent patency and reduce risk for tissue hyperplasia and tumor ingrowth. (wjgnet.com)
  • Selective stent placement (exclusive of carotid intervention) is indicated as secondary intervention following balloon angioplasty when the result is residual stenosis greater than 30% or a flow-limiting dissection. (medscape.com)
  • The LifeStent™ Vascular Stent System has achieved lasting results over the long term, with sustained effectiveness up to three years, and treatment superiority over balloon angioplasty. (bd.com)
  • Both percutaneous transluminal angioplasty (PTA) and stenting are commonly used endovascular treatment options for iliac artery occlusive disease. (cirse.org)
  • The indications have narrowed since stents and angioplasty can treat many without invasive surgery, but surgery continues to innovate as well. (oprah.com)
  • Percutaneous coronary interventions (PCI) include percutaneous transluminal coronary angioplasty (PTCA) with or without stent insertion. (msdmanuals.com)
  • The long-term outcome following repeat catheter-based treatments of previously implanted endothelialized stents is not well characterized. (medtronic.com)
  • Please reference product Instructions for Use for more information regarding indications, warnings, precautions, contraindications, and adverse events. (medtronic.com)
  • Clinical Outcomes of Second- versus First-Generation Carotid Stents: A Systematic Review and Meta-Analysis. (nih.gov)
  • Does stenting of left-sided colorectal cancer as a "bridge to surgery" adversely affect oncological outcomes? (thieme-connect.com)
  • Comparison of long-term outcomes of colonic stent as "bridge to surgery" and emergency surgery for malignant large-bowel obstruction: a meta-analysis. (thieme-connect.com)
  • Oncologic outcomes of self-expandable metallic stent as a bridge to surgery and safety and feasibility of minimally invasive surgery for acute malignant colonic obstruction. (thieme-connect.com)
  • However, there is a lack of evidence of the long-term good outcomes in patients with CVSS who underwent stenting. (benthamscience.com)
  • During the following 12~126 months (the median was 62) after stenting of the follow-up, 91.9% (57/62) of the patients obtained good outcomes. (benthamscience.com)
  • Abbott Vascular), for long term clinical outcomes, mainly designed to overcome the limitations of metallic stents. (researchandmarkets.com)
  • This study aims to describe the outcome of intravascular lithotripsy (IVL) when used with different indications and to assess the short- and long-term outcomes of IVL-facilitated percutaneous coronary intervention (PCI). (frontiersin.org)
  • All patients should be advised that endovascular treatment requires lifelong, regular follow-up to assess the integrity and performance of the implanted endovascular stent graft. (medtronic.com)
  • Silk Road Medica l, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that that the U.S. Food and Drug Administration (FDA) approved expanded indications for the ENROUTE stent to include patients at standard risk for adverse events from carotid endarterectomy (CEA). (infomeddnews.com)
  • Previously, the stent was approved for use only in patients with anatomic or physiological criteria that put them at high risk of complications from more invasive surgical procedures. (infomeddnews.com)
  • The ENROUTE Transcarotid Stent is intended to be used in patients at high risk for complications from CEA, in conjunction with the ENROUTE Transcarotid Neuroprotection System (NPS) during the procedure. (infomeddnews.com)
  • Advanta V12 is the first to market balloon expandable, fully encapsulated stent that has served more than 850,000 patients. (getinge.com)
  • To reduce the risk of stroke, carotid artery stenting (CAS) is performed and has shown to be effective in preventing from stroke in patients with severe carotid artery stenosis. (scirp.org)
  • Consecutive patients who were referred to neuroendovascular unit for carotid artery stent placement or EC-IC by-pass from January 2010 to October 2011 participated in the study. (scirp.org)
  • Methods: A total of 62 patients with imaging confirmed non-thrombotic and non-external compression CVSS were enrolled into this single center real-world cohort study after undergoing stenting, and were continuously followed up for more than 12 years. (benthamscience.com)
  • 42% of the patients suffered from visual loss, 11.3% pulsatile tinnitus, and 96.8% Papilledema before stenting. (benthamscience.com)
  • Patients with CVSS may get long-term benefit from stenting, especially when they are accompanied with severe IH. (benthamscience.com)
  • The feasibility of using a compressed interwoven Supera stent as a flow diverting device for popliteal aneurysms was recently demonstrated in patients. (springer.com)
  • 3,5 The subset of patients with raspy breathing and honking respond best to tracheal stenting, while the outcome of those with coughing as their primary sign is more difficult to predict. (mspca.org)
  • Biodegradable polymer sirolimus -eluting stents versus durable polymer everolimus -eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. (msdmanuals.com)
  • For operative patients who have an indication for an indwelling catheter, remove the catheter as soon as possible postoperatively, preferably within 24 hours, unless there are appropriate indications for continued use. (cdc.gov)
  • Further research is needed on the benefit of using a urethral stent as an alternative to an indwelling catheter in selected patients with bladder outlet obstruction. (cdc.gov)
  • Indications for pancreatoduodenectomy in patients undergoing lymphadenectomy for advanced gallbladder carcinoma. (cancercentrum.se)
  • Coronary stents are generally indicated to increase coronary vessel diameter in the setting of ischemia due to coronary blockage, either by a combination of acute recoil, arterial contraction of a previously treated segment, and/or local neointimal hyperplasia. (medscape.com)
  • Increasing FDA approvals for new coronary stents with upgraded technology along with huge pipeline products in the polymer segment such as polyesters, corrodible metals, polycarbonates, and bacterial-derived polymers will drive the market growth in the near future. (researchandmarkets.com)
  • Restoration of the lumen diameter with 8x59 mm Advanta V12 covered stents in RIA and LIA. (getinge.com)
  • Intraluminal tracheal stenting provides a minimally invasive, non-surgical method for the treatment of a narrow or obstructed tracheal lumen. (mspca.org)
  • For stents larger than 3mm in size, cardiac CT is an excellent tool for assessing in-stent lumen. (indiahospitaltour.com)
  • The GORE® VIABAHN® Device is a leader among stent grafts. (goremedical.com)
  • Coating the stents with medications to prevent aggressive attacking of the metal by the body has further reduced the chance of complications from re-stenosis. (oprah.com)
  • 1 Prior to recommending tracheal stenting, it is important to understand the indications, limitations, and complications of this palliative procedure. (mspca.org)
  • Background and Purpose: Cerebral Venous Sinus Stenosis (CVSS) usually results in severe Intracranial Hypertension (IH), which can be corrected by stenting immediately. (benthamscience.com)
  • Intracranial venous sinus stenting for benign intracranial hypertension: Clinical indications, technique, and preliminary results. (benthamscience.com)
  • However, many questions remain regarding the efficacy of acetazolamide, CSF shunting procedures and cerebral transverse venous sinus stenting. (bmj.com)
  • The dual-lined configuration led to residence times of 15-20 s, compared to 5-15 s for the single stent configurations. (springer.com)
  • Only Express LD Iliac and Biliary Stent was engineered to provide the perfect balance of compression resistance and conformability-without trade-off. (bostonscientific.com)
  • Stent placement should only be performed at hospitals where emergency coronary artery bypass graft surgery can be readily performed. (medtronic.com)
  • The long-term safety and effectiveness of the Valiant thoracic stent graft with the Captivia delivery system has not been established. (medtronic.com)
  • Strict adherence to the Valiant thoracic stent graft sizing guidelines as described in the Instructions for Use is expected when selecting the device size. (medtronic.com)
  • Non-clinical testing has demonstrated that the Valiant thoracic stent graft is MR-conditional. (medtronic.com)
  • Abraha I, Romagnoli C, Montedori A et al (2009) Thoracic stent graft versus surgery for thoracic aneurysm. (springer.com)
  • Clinical efficacy of endoscopic treatment for benign colorectal stricture: balloon dilatation versus stenting. (thieme-connect.com)
  • Primary stent placement is generally indicated as initial intervention for iliac, renal, subclavian, and carotid stenosis. (medscape.com)
  • Inclusion criteria included recent (within 30 days of the date of procedure) CTA of the head and neck, evidence of an carotid stenosis of more than 70% confirmed with conventional angiography or severe intracranial major artery stenosis with distinct low perfusion of the relevant regions, age older than 45 years, and selected by the vascular disease specialist as a suitable candidate for stent placement or EC-IC by-pass. (scirp.org)
  • In ruptured aneurysms, stent-assisted coil embolization is associated with increased morbidity and mortality and should only be considered when less risky options have been excluded. (ajnr.org)
  • There are several techniques to coil wide-neck aneurysms, such as balloon- or stent-assisted coiling, 1 ⇓ ⇓ ⇓ ⇓ ⇓ - 7 flow diversion, and, more recently introduced, the WEB aneurysm embolization system (Sequent Medical, Aliso Viejo, California). (ajnr.org)
  • The complication rate of stent-assisted coiling with early adverse events in ruptured aneurysms was 10 times higher than that in unruptured aneurysms. (ajnr.org)
  • Stent as bridge to surgery for left-sided malignant colonic obstruction reduces adverse events and stoma rate compared with emergency surgery: results of a systematic review and meta-analysis of randomized controlled trials. (thieme-connect.com)
  • Stent induced hemodynamic changes in the coronary arteries are associated with higher risk of adverse clinical outcome. (researchgate.net)
  • Local hemodynamics worsened with luminal protrusion of the stent and with stent malapposition, adverse high WSS and WSSG were identified around peak flow and throughout the cardiac cycle respectively. (researchgate.net)
  • For the Biomatrix stent, the adverse effect of thicker struts was mitigated by greater strut spacing, radial cell offset and flow-aligned struts. (researchgate.net)
  • The LifeStent™ Vascular Stent Systems, in varying sizes, have been studied in more than ten clinical trials in the United States and globally. (bd.com)
  • Care should be taken to control the position of the guide catheter tip during stent delivery, deployment, and balloon withdrawal. (medtronic.com)
  • The ureteric balloon catheter may be used in conjunction with a double J stent for additional drainage. (wikipedia.org)
  • On the end of the catheter is a tiny balloon and a metal mesh stent (tube). (medlineplus.gov)
  • 1 One study found that mean survival time in dogs treated for tracheal collapse with either tracheal stent or extraluminal tracheal rings was significantly shorter in dogs with bronchial collapse versus those without bronchial collapse (325 days vs. 1,600 days). (mspca.org)
  • A dual minimally invasive treatment approach was chosen, consisting of surgical diagnostic biopsies performed via lateral thoracotomy and transcardial placement of a self-expanding, covered, nitinol esophageal stent to palliate the obstruction. (avma.org)
  • Current iterations of veterinary tracheal stents are made of a self-expanding, nitinol mesh. (mspca.org)
  • Strut spacing, thickness, luminal protrusion, and malapposition were systematically investigated and a comparison made between two commercially available stents (Omega and Biomatrix). (researchgate.net)
  • The indications for revascularization have been immutable for decades, namely rest pain, ischemic ulceration, or gangrene. (nih.gov)
  • About Silk Road Medical's TCAR Procedure with the ENROUTE Transcarotid Neuroprotection and Stent System: TransCarotid Artery Revascularization is our clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. (infomeddnews.com)
  • Advanta V12/iCast is the only CBE stent with current long-term target lesion revascularization data. (getinge.com)
  • 9 Sebastian S, Johnston S, Geoghegan T, Torreggiani W, Buckley M. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. (thieme-connect.com)
  • The indications for peripheral vascular stents for known peripheral arterial disease are the same as those for open intervention. (medscape.com)
  • The LifeStent™ Vascular Stent is the only FDA-approved stent for the SFA and full popliteal artery. (bd.com)
  • The global bioresorbable vascular scaffold market is increasing efficiently from 2019 to 2027 accredited to increase in hospital admissions for heart-related disorders along with enhanced biosynthetic and polymer technology in the stent industry globally. (researchandmarkets.com)
  • Between February 2007 and March 2015, 45 acutely ruptured aneurysms and 47 unruptured aneurysms were treated with stent-assisted coiling. (ajnr.org)
  • Therefore, stent placement is generally avoided in acutely ruptured aneurysms in favor of clip ligation or other endovascular techniques that do not mandate dual antiplatelet therapy. (ajnr.org)
  • citation needed] Timotheus T. C. Overtoom, Peter L. Vijverberg, Hendrik W. van Es, Sandrine van Selm, Hans P. M. van Heesewijk (2009), "Treatment of Ureteropelvic Junction Obstruction Using a Detachable Inflatable Stent: Initial Experience", American Journal of Roentgenology, 192 (4): 1103-1106, doi:10.2214/AJR.08.1296, PMID 19304721{{citation}}: CS1 maint: multiple names: authors list (link) Thiruchelvam N. (wikipedia.org)
  • Tracheal stenting can be used for the treatment of tracheal stricture, tumors, and collapse. (mspca.org)
  • While reports of tracheal stenting for treatment of stricture and tumors are limited, there is a growing knowledge base surrounding the use of tracheal stents for treatment of tracheal collapse. (mspca.org)
  • This kind of treatment could also make it easier and less painful to insert stents into the ureter, which is sometimes done after a kidney stone is passed, to prevent the tube from becoming blocked or collapsing. (news-medical.net)
  • Target lesion failure may be more frequent when IVL is performed for the treatment of ISR due to calcium-mediated stent under expansion. (frontiersin.org)
  • Primary indications are treatment of Angina pectoris. (msdmanuals.com)
  • Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. (thieme-connect.com)
  • The ENROUTE Transcarotid NPS is a first in class device used to directly access the common carotid artery and initiate high rate temporary blood flow reversal to protect the brain from stroke while delivering and implanting the ENROUTE Transcarotid Stent. (infomeddnews.com)
  • As a general consensus, a stenotic or occlusive lesion of the aortoiliac artery can be treated successfully by PTA and provisional stenting. (cirse.org)
  • Background: To compare the neuropsychological consequences after carotid artery stenting (CAS) and extracranial-intracranial by-pass (EC-IC by-pass). (scirp.org)
  • Liu, L. and Zhou, Y. (2015) Effect of Carotid Artery Stenting and Extracranial-Intracranial By-Pass on Cognitive Function: Preliminary Results. (scirp.org)
  • The stent stays in place and hold the artery open. (apollohospitals.com)
  • The indications for EC-IC bypass surgery were haemodynamic compromise due to atherosclerotic occlusive cerebrovascular disease which was demonstrated by the MRI perfusion imaging. (scirp.org)
  • 8 With the use of stents or flow diverters, complication rates tend to be higher than with selective coiling or balloon-assisted coiling because of the thrombogenicity of the devices and the need for dual antiplatelet medication with inherent risk in the postoperative period. (ajnr.org)
  • Insert catheters only for appropriate indications (see Table 2 for guidance), and leave in place only as long as needed. (cdc.gov)
  • Farmacie Online Viagra.51 billion clopidogrel indications stent . (onlinehome.us)
  • Viagra Pharmacie Online clopidogrel indications stent . (onlinehome.us)
  • Online Apotheke Niederlande Cialis clopidogrel indications stent . (onlinehome.us)
  • Cialis 10Mg Prix Pharmacie clopidogrel indications stent . (onlinehome.us)
  • Buy Viagra In Bulk clopidogrel indications stent . (onlinehome.us)
  • 26 Mar 2015 clopidogrel indications stent . (onlinehome.us)
  • acheter dexametasona 15 g pharmacie en ligne ordonnance clopidogrel indications stent . (onlinehome.us)
  • Pharmacie pour vente clopidogrel indications stent . (onlinehome.us)
  • Subsequent stent blockage may require repeat dilatation of the arterial segment containing the stent. (bostonscientific.com)
  • The mean trans-stenotic pressure gradients were 6~43 mmHg prior to stenting and returned to 0~4 mmHg after stent placement. (benthamscience.com)
  • Stents for coronary arteries are expandable wire mesh cylinders that help hold stenotic areas open. (msdmanuals.com)
  • The Advanta V12 balloon expandable covered stent is not available in the U.S. (getinge.com)
  • Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. (thieme-connect.com)
  • Fully covered self-expandable metal stents (FCSEMS) represent the latest advancement of metal biliary stents used to endoscopically treat a variety of obstructive biliary pathology. (wjgnet.com)
  • Fully covered self-expandable metal stents (FCSEMS) are composed of a metal alloy tubular mesh with a synthetic covering to minimize tumor ingrowth. (wjgnet.com)
  • A 1.5-cm caudal and aboral migration of the stent is apparent. (avma.org)
  • D - Image obtained 8 months after repositioning of the stent, showing complete migration of the stent into the stomach. (avma.org)
  • Novel anchoring designs have been effective at addressing the common problem of stent migration with FCSEMS. (wjgnet.com)
  • Tracheal stents are typically oversized by 2-3 mm, compared to the size of the expanded trachea, in order to minimize future foreshortening and migration. (mspca.org)
  • Reasons for internal migration of plastic bile duct stents and there methods of retrieval. (who.int)
  • Furthermore, stent fractures occur with a reported incidence of 19% at a median follow-up of 40 months, associated with clinical symptoms in 38% of cases [ 2 ]. (springer.com)